188 related articles for article (PubMed ID: 23441133)
21. Urokinase induces stromal cell-derived factor-1 expression in human hepatocellular carcinoma cells.
Hsu WH; Chen CN; Huang HI; Lai YL; Teng CY; Kuo WH
J Cell Physiol; 2012 Feb; 227(2):697-704. PubMed ID: 21465475
[TBL] [Abstract][Full Text] [Related]
22. DNA methyltransferase 1 and 3B activate BAG-1 expression via recruitment of CTCFL/BORIS and modulation of promoter histone methylation.
Sun L; Huang L; Nguyen P; Bisht KS; Bar-Sela G; Ho AS; Bradbury CM; Yu W; Cui H; Lee S; Trepel JB; Feinberg AP; Gius D
Cancer Res; 2008 Apr; 68(8):2726-35. PubMed ID: 18413740
[TBL] [Abstract][Full Text] [Related]
23. GATA6 promotes colon cancer cell invasion by regulating urokinase plasminogen activator gene expression.
Belaguli NS; Aftab M; Rigi M; Zhang M; Albo D; Berger DH
Neoplasia; 2010 Nov; 12(11):856-65. PubMed ID: 21076612
[TBL] [Abstract][Full Text] [Related]
24. Expression analysis of the epigenetic methyltransferases and methyl-CpG binding protein families in the normal B-cell and B-cell chronic lymphocytic leukemia (CLL).
Kn H; Bassal S; Tikellis C; El-Osta A
Cancer Biol Ther; 2004 Oct; 3(10):989-94. PubMed ID: 15467427
[TBL] [Abstract][Full Text] [Related]
25. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
26. BRCA1 affects global DNA methylation through regulation of DNMT1.
Shukla V; Coumoul X; Lahusen T; Wang RH; Xu X; Vassilopoulos A; Xiao C; Lee MH; Man YG; Ouchi M; Ouchi T; Deng CX
Cell Res; 2010 Nov; 20(11):1201-15. PubMed ID: 20820192
[TBL] [Abstract][Full Text] [Related]
27. Aldosterone reprograms promoter methylation to regulate αENaC transcription in the collecting duct.
Yu Z; Kong Q; Kone BC
Am J Physiol Renal Physiol; 2013 Oct; 305(7):F1006-13. PubMed ID: 23926181
[TBL] [Abstract][Full Text] [Related]
28. Role of LFB3 in cell-specific cAMP induction of the urokinase-type plasminogen activator gene.
Marksitzer R; Stief A; Menoud PA; Nagamine Y
J Biol Chem; 1995 Sep; 270(37):21833-8. PubMed ID: 7665606
[TBL] [Abstract][Full Text] [Related]
29. Differential recruitment of methyl CpG-binding domain factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4.
Gu P; Xu X; Le Menuet D; Chung AC; Cooney AJ
Stem Cells; 2011 Jul; 29(7):1041-51. PubMed ID: 21608077
[TBL] [Abstract][Full Text] [Related]
30. Urokinase signaling through its receptor protects against anoikis by increasing BCL-xL expression levels.
Alfano D; Iaccarino I; Stoppelli MP
J Biol Chem; 2006 Jun; 281(26):17758-67. PubMed ID: 16632475
[TBL] [Abstract][Full Text] [Related]
31. Binding of Sp1 to the proximal promoter links constitutive expression of the human uPA gene and invasive potential of PC3 cells.
Ibañez-Tallon I; Ferrai C; Longobardi E; Facetti I; Blasi F; Crippa MP
Blood; 2002 Nov; 100(9):3325-32. PubMed ID: 12384434
[TBL] [Abstract][Full Text] [Related]
32. Reversal of the hypomethylation status of urokinase (uPA) promoter blocks breast cancer growth and metastasis.
Pakneshan P; Szyf M; Farias-Eisner R; Rabbani SA
J Biol Chem; 2004 Jul; 279(30):31735-44. PubMed ID: 15150277
[TBL] [Abstract][Full Text] [Related]
33. Ets-1 positively regulates expression of urokinase-type plasminogen activator (uPA) and invasiveness of astrocytic tumors.
Nakada M; Yamashita J; Okada Y; Sato H
J Neuropathol Exp Neurol; 1999 Apr; 58(4):329-34. PubMed ID: 10218628
[TBL] [Abstract][Full Text] [Related]
34. IL-1β-stimulated urokinase plasminogen activator expression through NF-κB in gastric cancer after HGF treatment.
Lee KH; Choi EY; Koh SA; Kim MK; Jang BI; Kim SW; Kim JR
Oncol Rep; 2014 May; 31(5):2123-30. PubMed ID: 24626561
[TBL] [Abstract][Full Text] [Related]
35. Molecular mechanisms of transactivation and doxorubicin-mediated repression of survivin gene in cancer cells.
Estève PO; Chin HG; Pradhan S
J Biol Chem; 2007 Jan; 282(4):2615-25. PubMed ID: 17124180
[TBL] [Abstract][Full Text] [Related]
36. Urokinase-type plasminogen activator gene regulation by polyomavirus middle-T antigen.
Besser D; Urich M; Sakaue M; Messerschmitt A; Ballmer-Hofer K; Nagamine Y
Oncogene; 1995 Dec; 11(11):2383-91. PubMed ID: 8570190
[TBL] [Abstract][Full Text] [Related]
37. uPAR and cathepsin B shRNA impedes TGF-β1-driven proliferation and invasion of meningioma cells in a XIAP-dependent pathway.
Gogineni VR; Gupta R; Nalla AK; Velpula KK; Rao JS
Cell Death Dis; 2012 Dec; 3(12):e439. PubMed ID: 23222509
[TBL] [Abstract][Full Text] [Related]
38. Urokinase-induced smooth muscle cell responses require distinct signaling pathways: a role for the epidermal growth factor receptor.
Nicholl SM; Roztocil E; Davies MG
J Vasc Surg; 2005 Apr; 41(4):672-81. PubMed ID: 15874933
[TBL] [Abstract][Full Text] [Related]
39. The BRAF(V600E) causes widespread alterations in gene methylation in the genome of melanoma cells.
Hou P; Liu D; Dong J; Xing M
Cell Cycle; 2012 Jan; 11(2):286-95. PubMed ID: 22189819
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of urokinase-type plasminogen activator by insulin-like growth factor-I depends upon phosphatidylinositol-3 kinase and mitogen-activated protein kinase kinase.
Dunn SE; Torres JV; Oh JS; Cykert DM; Barrett JC
Cancer Res; 2001 Feb; 61(4):1367-74. PubMed ID: 11245436
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
